Clinical Trial Details
— Status: Recruiting
Administrative data
NCT number |
NCT05899127 |
Other study ID # |
hanyi20230118 |
Secondary ID |
|
Status |
Recruiting |
Phase |
Phase 4
|
First received |
|
Last updated |
|
Start date |
July 22, 2023 |
Est. completion date |
July 31, 2024 |
Study information
Verified date |
January 2024 |
Source |
Second Hospital of Shanxi Medical University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The intravenous injection of lidocaine during the perioperative period has been widely used
in various types of surgeries. Its clinical effect includes reducing stress response during
anesthesia, decreasing pain and opioid consumption, lowering the incidence of postoperative
nausea, vomiting, cognitive dysfunction, and reducing the injection pain of propofol.
However, despite the positive impact of lidocaine on surgical patients, its mechanism of
action remains unclear. Serum N/OFQ is a neurotransmitter that plays an important role in
regulating pain and emotion. Therefore, this study aims to explore the effects of
perioperative intravenous injection of lidocaine on stress responses in surgical patients, as
well as its mechanism of action, and whether Serum N/OFQ participates in this process.
Description:
We hypothesize that intravenous injection of lidocaine during the perioperative period can
reduce expression of endogenous opioid peptides, which in turn can decrease secretion of IL-6
and TNF-α, ultimately leading to a reduction in perioperative stress response. This
randomized controlled trial will be conducted at the Second Hospital of Shanxi Medical
University in China, with the aim of observing changes in stress-related indicators (blood
pressure, heart rate, heart rate variability, IL-6, TNF-α, as well as Serum N/OFQ ) between
patients undergoing abdominal surgery under total intravenous general anesthesia with and
without lidocaine injection. Lidocaine will be administered as a loading dose during
anesthesia induction and continued via infusion until the end of anesthesia maintenance, with
appropriate depth of anesthesia or BIS readings utilized for monitoring anesthesia depth.
Routine monitoring parameters, including blood pressure, heart rate, SpO2, and
electrocardiogram, will be recorded and analyzed. Blood samples will be collected 30 minutes
before anesthesia induction, 1 minute after tracheal intubation, and at the end of surgery.
The use of lidocaine will be evaluated for its impact on perioperative stress response in
patients undergoing abdominal surgery, with the relationship to changes in levels of
endogenous opioid peptides explored.